MedTrace Logo

Wolffia Globosa (Mankai) and Glycemic Control Among Patients With Type 2 Diabetes

NCT04945109 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-11-30

No results posted yet for this study

Summary

The investigators primarily aim to explore the effect of daily additive supplementation of Mankai on glucose control among participants with T2D.

Conditions

Interventions

OTHER

Mankai beverage

Recommended background healthy diet with Mankai supplementation after main meal (300 ml)

OTHER

Water (control)

Recommended background healthy diet with water supplementation after main meal (300 ml)

Sponsors & Collaborators

  • Sheba Medical Center

    collaborator OTHER_GOV

  • Ben-Gurion University of the Negev

    lead OTHER

Principal Investigators

  • Amir Tirosh, MD PhD · Sheba Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-19
Primary Completion
2021-11-18
Completion
2021-11-18

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04945109 on ClinicalTrials.gov